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Abstract
Despite the increasing availability of online patient portals
that provide access to electronic health records, little is known 
about their adoption by patients. We systematically reviewed 
the literature to investigate adoption of patient portals across
studies. We searched MEDLINE and Scopus to identify 
relevant papers. We included 40 studies: 24 were controlled 
experiments, with prospective data collection in an actively 
recruited population; 16 were real-world experiments, with 
adoption being evaluated retrospectively after system
deployment in clinical practice. Our meta-analysis showed an 
overall mean adoption rate of 52% (95% Confidence Interval 
[CI], 42 to 62%). Rates differed markedly between study
types: controlled experiments yielded a mean adoption rate of 
71% (95% CI 64 to 79%), compared to 23% (95% CI, 13 to 
33%) in real-world experiments. This difference was 
confirmed in a meta-regression analysis of the influence of
study characteristics on adoption rates. Our findings suggest 
that adoption rates reported in controlled studies do not
reflect those in everyday clinical practice. Until we 
understand how to effectively increase adoption, patient 
portals are unlikely to consistently lead to improvements in
care processes and health outcomes.
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Introduction
Patient portals are online services that allow people to have 
access to their electronic health records (EHRs) and support 
basic activities such as booking appointments, recording 
symptoms, and communicating with healthcare providers [1, 
2]. They are considered a valuable instrument to engage 
patients in having a more active role in their care [3–8] and aid
self-management [8–10]. Many patient portals are developed 
for people with long-term conditions [9, 11].
Patient portals are increasingly available [1, 12, 13], but their 
impact on health outcomes has yet to be established [14–18].
Previous systematic reviews found positive effects on patient 
engagement and satisfaction [14, 15, 17, 18], but evidence on
the effect of patient portal use on care processes and health 
outcomes is conflicting [14, 15, 18]. Our understanding of this 
variation in impact is currently limited [14, 15]. This might be 
related to the fact that published evaluations tend to focus on 
clinical endpoints, without considering the complex process 
that leads to them [19, 20].
As proposed by Coiera in his ‘information value chain’ [20], 
for any health information system to have impact, users first 
need to adopt the system and effectively interact with it (step 
1) in order to receive information (step 2), which might then 
influence their decision making (step 3). This might lead to 
improved care processes (step 4), and, under beneficial 
conditions, to better health outcomes (step 5). Although not 
sufficient, good results are necessary at each step to achieve 
eventual positive impact on clinical endpoints [20]. Following
Coiera’s information value chain, evaluating adoption rates is
essential for understanding the (lack of) effect of patient 
portals on decision making, care processes and health 
outcomes.
Although individual patient portal studies may have reported 
on adoption rates [21–23], up till now no study has summa-
rized these rates across studies. Also, adoption rates in con-
trolled experiments may not always translate well to a real life 
context [15]. This disconnect between findings from con-
trolled and real-world experiments might partly be explained 
by the former being more likely to include strategies for opti-
mizing recruitment and minimizing attrition than the latter
[24]. For example, a study in primary care showed that pa-
tients in practices with a more active strategy to promote por-
tal use were more likely to be registered users compared to
those in practices with a less active or no strategy [25].
Therefore, we systematically reviewed the literature on patient 
portals to investigate adoption rates across individual studies, 
and how rates might differ between controlled and real-world 
experiments.
Methods
We followed the PRISMA statement [26] to design and report 
our systematic review and meta-analysis, where applicable.
Search strategy
We used the search strategy that we developed for a broader 
literature review on methodological approaches to evaluate
patient portal usage, usability and effect on decision making
(i.e. Coiera’s information value chain steps 1-3). We searched
for English language articles in MEDLINE via Ovid and in 
Scopus by combining subheadings and text words for patient 
portals with those referring to system usage, usability, and 
decision-making (full searches available at [27]). The searches 
were performed on the 18th of July 2016.
c
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Selecting relevant studies
We considered studies relevant if they:
 Evaluated patient portals, using the definition of Irizarry 
et al. [2]: systems providing patients with access to their 
EHRs, and allowing them to enter health data or share 
information with their healthcare providers. We excluded 
studies on systems only providing educational material, 
or online booking or secure messaging functionalities.
 Had patients, carers, or healthy volunteers from the 
general population as the study sample, excluding those 
testing the system only within the research team.
 Reported sufficient information to determine portal
adoption rate in the study population. Adoption was
defined as the % of eligible patients who logged in at 
least once or—if this information was not available—had 
an active account during the study period. We excluded 
studies that only reported other types of usage statistics 
(e.g. frequency of use).
 Collected data on adoption through system interaction 
logs. Studies retrospectively asking patients about their 
portal use in surveys were excluded because such data 
lack in objectivity [28] and are known to be affected by 
recall bias [19]. We also excluded studies investigating 
intended use.
 Were peer-reviewed original articles (including 
conference papers) or systematic reviews in English, 
while excluding conference abstracts, narrative reviews, 
editorials, view point papers and grey literature.
After removing the duplicates from the Ovid and Scopus 
searches, the principal reviewer (PF) independently screened 
the titles and abstracts of all studies, whereas two secondary 
reviewers (PB; SvdV) did 50% each. For studies considered 
potentially relevant, we retrieved the full papers and two 
reviewers independently identified those meeting our 
inclusion criteria. At each stage of the review process, 
disagreement was solved through discussion.
Data extraction
We built a data abstraction form on the basis of previous 
systematic reviews on patient portals [17, 29] and health 
information systems evaluations [19, 30, 31], and pilot-tested
it among the authors (PF, SvdV, MV, NP). The final form 
included items related to: general study characteristics; study 
type (controlled versus real-world experiment); study 
population; patient portal functionalities (data access; data 
recording; data sharing); number of potential patient portals 
users; number of patients who logged in at least once or had 
an active account during the study period. For real-world 
experiments, we additionally extracted information on 
strategies aimed at increasing patient portal adoption.
Controlled experiments were defined as any study where 
patients were actively recruited to participate in research and 
where data were collected prospectively. This included 
experiments with single groups as well as those with multiple 
groups (with participants being allocated either randomly or 
non-randomly), with the number of potential users equalling
the number of participants recruited into the study. In case of 
multiple groups, we calculated this number across groups. 
Real-world experiments concerned observational studies that 
retrospectively evaluated adoption after a patient portal had 
been deployed in clinical practice. In this case, the number of 
potential users were all eligible patients in the clinical context 
of interest who should have been offered access to the portal.
One author (PF) extracted the data and performed the data 
synthesis for all studies. Uncertainties during the data 
extraction process were addressed and resolved by discussion 
with a second member of the research team (SvdV).
Data synthesis and analysis
We organised results according to study type. We calculated 
the mean adoption rate and 95% confidence interval (CI), both 
overall and stratified for study type. We also conducted a
random-effects meta-regression analysis to evaluate the 
influence of the study and patient portal characteristics on 
adoption rates using the metafor R package [32]. Prior to the 
regression analysis, we performed a logit transformation on 
adoption rates reported in the included studies [33]. From the 
meta-regression coefficients estimates, we calculated Odds 
Ratios (ORs) and 95% CI. Furthermore, as prescribed by 
Stevens et al. [33], coefficients estimates were back-
transformed to the proportional scale by using the mean
adoption rate across all studies as anchor value. This gave us 
the estimated effect of each model covariate in a study with an 
avarage adoption rate.
Results
Figure 1 shows the flow diagram of our screening and
selection process that yielded 40 relevant studies.
Figure 1 - Flow diagram of selecting relevant studies.
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Study characteristics
Table 1 presents the general characteristics of included studies
(extracted information and the full reference for each 
indvidual study is available at [27]). We identified 24
controlled and sixteen real-world experiments. The majority of 
included studies were published after 2010, conducted in the 
United States, and had a duration of 1 to 2 years. The vast 
majority of patient portals under evaluation provided some 
kind of access to patients' EHR as well as to data recording 
functionalities. Overall, the two study types had similar 
characteristics, with the main difference being the number of
potential portal users. In particular, we found smaller numbers 
of potential users in controlled compared to real-world 
experiments, with the majority reporting values below 1,000 
and above 10,000 people, respectively.
Table 1 - Characteristics of included studies and patient 
portal functionalities (N=40).
Controlled 
experiments 
(N=24)
Real-world
experiments
(N=16)
Year of publication 
< 2005 2 (8) /
2005 to 2010 5 (21) 4 (25)
> 2010 17 (71) 12 (75)
Geographical location
United States 17 (71) 11 (69)
Europe 4 (17) 4 (25)
Other 3 (13) 1 (6)
Study population
Patients with a 
specific condition 7 (29) 6 (38)
General 
population 6 (25) 3 (19)
Primary care 6 (25) 6 (38)
Other 5 (21) 1 (6)
Number of potential 
users a)
<100 8 (33) /
100 to 1,000 13 (54) 1 (6)
1,000 to 10,000 2 (8) 5 (31)
> 10,000 1 (4) 10 (63)
Study length
<1 year 8 (33) 2 (13)
1 to 2 years 13 (54) 9 (56)
> 2 years 2 (8) 5 (31)
Main patient portal 
functionalities b)
Data access 20 (83) 15 (94)
Data recording 18 (75) 12 (75)
Data sharing 10 (42) 6 (38)
a) Calculated as: number of patients recruited into the study for controlled 
experiments; number of people eligible to be offered access to the patient 
portal for real-world experiments.
b) Categories are not mutually exclusive.
Strategies to increase adoption in real-world experiments
Five of sixteen (31%) real-world experiments did not report 
any strategy to promote adoption. The remaining eleven re-
ported a range of strategies aimed at increasing patient portal 
adoption rates. In five studies, eligible patients were directly
invited (i.e. via mail or staff) or provided with system creden-
tials that they only had to activate. Four studies disseminated
promotional material to raise people’s awareness of the portal 
via different channels, such as flyers and posters in waiting 
areas, directed electronic mailings or via staff. In three studies, 
computers were available in clinical settings for patients to 
access the portal. Lastly, two offered user training, one had 
personnel available onsite to support patients with using the 
portal, and one offered a help desk service.
Patient portal adoption rates
The overall mean adoption rate across all included studies was 
52% (95% CI, 42 to 62%). When stratifying for study type, 
controlled experiments had a mean adoption rate of 71% (95% 
CI, 64 to 79%), compared to 23% (95% CI, 13 to 33%) for 
real-world experiments.
The results from the meta-regression are shown in Table 2. 
Study type was the only statistically significant covariate in 
the model after adjusting for all other study and patient portal 
characteristics. In particular, the OR for controlled versus real-
world experiments was 10.8 (95% CI 3.2 to 36.3). This would 
translate to a difference in adoption rate of 40% (95% CI, 26 
to 46%).
Table 2 - Estimates of ORs for adoption and change in 
adoption rate (%). Bold coefficients are stastically significant.
Study characteristics and 
portal functionalities
ORs
[95% CI]
Change in 
adoption 
(%) a)
[95% CI]
Study length (per year increase) 0.7 [0.4,1.4] -7 [-21,8]
Study type 
Real-world experiment 
(reference category)
Controlled experiment 10.8 [3.2,36.3] 40 [26,46]
Publication year
<2005 (reference category)
2005 to 2010 0.4 [0.0,7.0] -24 [-50,36]
>2010 1.0 [0.1,18.7] 0 [-46,43]
Geographical location
Others (reference category)
United States 1.3 [0.3,5.9] 7 [-27,34]
Study population
General population 
(reference category)
Patients with a specific 
condition 0.7 [0.1,4.2] -7 [-39,30]
Primary care patients 0.7 [0.1,3.6] -9 [-39,28]
Other 1.4 [0.2,9.5] 8 [-34, 39]
Patient portals functionalities b)
Data access provided 0.5 [0.1,3.3] -17 [-45,26]
Data recording provided 0.6 [0.1,2.2] -14 [-38,19]
Data sharing provided 1.9 [0.5,7.9] 16 [-18,38]
Abbreviations: CI, Confidence interval; ORs, Odds ratios.
a) Change in adoption for a study with underlying adoption rate equal to 52% 
(i.e. mean value across all included studies).
b) Each of the three functionalities was included in the model as a binary 
variable, with ‘Data access/recording/sharing not provided’ as the reference 
category.
Discussion
Summary of the findings
We performed a systematic review of the literature and a 
meta-analysis of adoption rates of patient portals. The overall 
mean adoption rate was 52% (95% CI, 42 to 62%). Despite 
the majority of real-world experiments reporting the use of 
strategy to promote adoption, rates evaluated in real life were 
markedly lower compared to those evaluated in controlled 
experiments (23 and 71%, respectively); most of the other 
study characteristics and patient portal functionalities were
similar between study types. A meta-regression analysis
confirmed these findings.
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Relation to other studies
Our meta-analysis is the first comprehensive, systematic
review of studies reporting patient portal adoption rates. We 
are also the first to provide a summary statistic of adoption 
rates across individual studies, while quantifying the influence 
of study type and other characteristics on the rates reported.
Our findings complement what was found by Irizarry et al. 
[2]. Whereas they reported on the barriers to adoption of 
patient portals (i.e. involving personal characteristics, system 
usability, provider endorsement and security), our study 
provides evidence on the size of the problem of suboptimal 
adoption.
Our study confirms what was suggested by Giardina et al. [15]
in their systematic review of randomised controlled trials 
(RCTs) of patient portals, who hypothesised that evaluation of 
adoption in clinical practice may give different results from 
those obtained in RCTs. Two main reasons may underly their 
hypothesis. First, patients who agree to participate in this type 
of study are generally interested in and motivated to use the 
patient portal [34]. Second, patients who are recruited for a 
research study know that their actions will be studied, which is 
likely to change participants’ behaviours (i.e. Hawthorne 
effect). Both reasons may increase the levels of adoption.
What is the meaning of the findings and what are their 
implications?
In the studies that we labelled real-world experiments, it was 
more difficult to assess the denominator than in controlled 
experiments. For the former, the denominator was commonly 
set as the largest group of patients who could have used the 
portal, while for the latter it was the number of patients to 
whom the portal was actively offered as part of the study. Due 
to this difference in counting, real-world experiments were 
more likely to have lower adoption rates, which may have 
resulted in our overestimating the difference between the two 
study types.
As prescribed by Coiera’s information value chain [20], to 
increase the probability of improving care processes and 
health outcomes we first need to ensure that the previous steps 
in the chain have been taken successfully. Our study showed
that when deployed in a real-world context, most patient 
portals failed to obtain high adoption rates. It is noteworthy 
that our findings were based on a rather crude definition of 
adoption (i.e. at least one login or activated account during the 
study period). However, in order for patients to receive 
substantial information from portals that might affect their 
decisions, more may be required than just activating a user 
account or logging in only once. Furthermore, applying a 
more sophisticated definition of adoption (e.g. logging in 
multiple times over a sustained period of time) is expected to 
have resulted in even lower adoption rates for both study 
types.
Low adoption rates were obtained despite real-world 
experiments reporting to have used active strategies to 
maximise enrolment and facilitate portal use. Therefore, the 
problem might not only be related to if and how patient portals 
are promoted, but also to whether patients consider portals 
relevant for self-managing their condition in everyday life. In 
this regard, a positive example comes from Kaiser 
Permanente, which was the only real-world experiment
obtaining high adoption rates (i.e. 62%) in a large population
[35]. Kaiser Permanente is the most widely used privately 
owned patient portal in the world [36]. They have their patient 
portal at the centre of their business model. Patients, in
addition to gaining access to their EHRs, can use the platform 
to download documents and forms necessary to use Kaiser 
Permanente services [35]. A previous study further showed 
how patient-centeredness and making information actionable 
are other main components of their success [37].
Limitations
This systematic review has two main limitations. First, some 
steps of the review process were not performed by two 
independent researchers. Therefore, these steps might have 
been more prone to errors than others; it was up to the 
discretion of the primary reviewer to discuss items that were 
less straightforward to extract and required more 
interpretation. Second, with 40 studies included, the meta-
regression analysis might have been underpowered to detect
statistically significant effects for factors other than the study 
type. However, as shown in Table 1, study characteristics 
were similar between the two types of studies; therefore we do 
not expect this to have influenced our results.
Conclusion
Overall, studies on patient portals found that half of the 
targeted population adopted the intervention. However, this 
number was markedly lower when evaluated in real-world 
experiments, with only one in four patients adopting the portal 
once deployed in clinical practice. Therefore, patient portals 
are unlikely to influence clinical endpoints in a real-world 
setting. Future studies in this field should focus on identifying 
factors and processes that positively affect adoption of patient 
portals in clinical practice.
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